^
BIOMARKER:

AR-V7 expression

AR-V7 expression
Prostate Cancer
nivolumab + ipilimumab
Sensitive: C2 – Inclusion Criteria
AR-V7 expression
Prostate Cancer
EPZ-5676
Sensitive: D – Preclinical
AR-V7 expression
Prostate Cancer
EPZ004777
Sensitive: D – Preclinical
AR-V7 expression
Prostate Cancer
enzalutamide + EPI-7170
Sensitive: D – Preclinical